Prudential Financial Inc Athenex, Inc. Transaction History

Prudential Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $26,793 - $59,468	65,350 New	65,350 $27,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $25,562 - $55,260	-18,796 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $55,824 - $90,972	18,796 New	18,796 $57,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $92,916 - $128,480	-25,045 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$4.08 - $14.75 $632,910 - $2.29 Million	-155,125 Reduced 86.1%	25,045 $108,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $2.78 Million - $3.53 Million	-251,660 Reduced 58.28%	180,170 $1.99 Million
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $302,423 - $428,875	-29,476 Reduced 6.39%	431,830 $5.23 Million
Q2 2020 Aug 12, 2020	SELL	$7.11 - $13.76 $21,692 - $41,981	-3,051 Reduced 0.66%	461,306 $6.35 Million
Q1 2020 May 12, 2020	SELL	$5.71 - $15.85 $569,840 - $1.58 Million	-99,797 Reduced 17.69%	464,357 $3.59 Million
Q4 2019 Feb 11, 2020	BUY	$9.6 - $17.75 $4.73 Million - $8.75 Million	492,774 Added 690.35%	564,154 $8.61 Million
Q3 2019 Nov 13, 2019	BUY	$12.16 - $21.0 $726,766 - $1.26 Million	59,767 Added 514.66%	71,380 $867,000
Q4 2018 Feb 07, 2019	BUY	$10.24 - $15.49 $118,917 - $179,885	11,613 New	11,613 $147,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.